Nagata Naoyoshi, Sakamoto Kayo, Arai Tomohiro, Niikura Ryota, Shimbo Takuro, Shinozaki Masafumi, Ihana Noriko, Sekine Katsunori, Okubo Hidetaka, Watanabe Kazuhiro, Sakurai Toshiyuki, Yokoi Chizu, Yanase Mikio, Akiyama Junichi, Uemura Naomi, Noda Mitsuhiko
Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Department of Diagnostic Radiology, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
PLoS One. 2015 Apr 23;10(4):e0123993. doi: 10.1371/journal.pone.0123993. eCollection 2015.
This study aims to investigate the association between body mass index (BMI) or intra-abdominal fat measured by computed tomography (CT) and bowel symptoms.
A cohort of 958 Japanese adults who underwent colonoscopy and CT and completed questionnaires after excluding colorectal diseases was analyzed. Six symptoms (constipation, diarrhea, loose stools, hard stools, fecal urgency, and incomplete evacuation) using a 7-point Likert scale were evaluated between baseline and second questionnaire for test-retest reliability. Associations between BMI, visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and symptom score were analyzed by a rank-ordered logistic model, adjusting for age, sex, smoking, and alcohol consumption, hypertension, diabetes mellitus, and dyslipidemia.
Some bowel symptom scores were significantly (p<0.05) different between the age groups, sexes, smoking, and alcohol consumption. In multivariate analysis, constipation was associated with low BMI (p<0.01), low VAT area (p = 0.01), and low SAT area (p<0.01). Moreover, hard stools was associated with low BMI (p<0.01) and low SAT area (p<0.01). The remaining symptoms were not significantly associated with BMI or intra-abdominal fat. Test-retest reliability of bowel symptom scores with a mean duration of 7.5 months was good (mean kappa, 0.672).
Both low BMI and low abdominal fat accumulation appears to be useful indicators of increased risk for constipation and hard stools. The long-term test-retest reliability of symptom score suggests that bowel symptoms relevant to BMI or visceral fat remain consistent over several months.
本研究旨在调查体重指数(BMI)或通过计算机断层扫描(CT)测量的腹内脂肪与肠道症状之间的关联。
对958名接受结肠镜检查和CT检查并在排除结直肠疾病后完成问卷调查的日本成年人队列进行分析。在基线和第二次问卷调查之间,使用7点李克特量表评估六种症状(便秘、腹泻、稀便、硬便、排便急迫感和排便不尽)的重测信度。通过等级有序逻辑模型分析BMI、内脏脂肪组织(VAT)、皮下脂肪组织(SAT)与症状评分之间的关联,并对年龄、性别、吸烟、饮酒、高血压、糖尿病和血脂异常进行校正。
不同年龄组、性别、吸烟和饮酒情况之间,一些肠道症状评分存在显著差异(p<0.05)。在多变量分析中,便秘与低BMI(p<0.01)、低VAT面积(p = 0.01)和低SAT面积(p<0.01)相关。此外,硬便与低BMI(p<0.01)和低SAT面积(p<0.01)相关。其余症状与BMI或腹内脂肪无显著关联。平均持续时间为7.5个月的肠道症状评分的重测信度良好(平均kappa值为0.672)。
低BMI和低腹部脂肪堆积似乎都是便秘和硬便风险增加的有用指标。症状评分的长期重测信度表明,与BMI或内脏脂肪相关的肠道症状在几个月内保持一致。